Monthly Note

Hello!

Last month I said no news is good news, this month we have a little more to talk about. The Delta variant seems to be most of the headlines these days, and it seems to be getting serious, more on that below. I apologize for the delay in this month’s letter, the last of my summer visitors left Friday, so I was a bit behind with stuff like this.

I’ll leave the issue of public health to the medical community, but in terms of the market impact, I think this new wave will play out differently than the first. Now that vaccines are widely available, The US seems to be focusing on a more “live with the virus” plan. I don’t think we’ll see widespread shutdowns, layoffs, and further supply issues. We may get a fear based sell off, but I really don’t foresee it worse than 2020’s spring sell off. A market dip wouldn’t be a bad thing at this point, it would give us a chance to rebalance and adjust for the future. As always, only time will tell.

I am in the office the rest of summer and Lynn is reaching out to set a lot of appointments. My plan is still to travel in the early fall to see many out of state clients, but that will depend on the status of travel in the US and risk of exposure to the clients I would be traveling to see. I will be reaching out in the near future to start setting plans.

Everyone stay healthy and happy!

Opinions voiced in this material are for general information only and are not intended to provide specific advice or recommendations for any individual. All performance referenced is historical and is no guarantee of future results. The economic forecasts set forth in this material may not develop as predicted and there can be no guarantee that strategies promoted will be successful. Because of their narrow focus, investments concentrated in certain sectors or industries will be subject to greater volatility and specific risks compared with investing more broadly across many sectors, industries and companies.